CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Operating expenses
Research and development	$ 25,250	$ 22,194	$ 73,617	$ 73,451
General and administrative	8,544	7,100	23,654	27,014
Total operating expenses	33,794	29,294	97,271	100,465
Loss from operations	(33,794)	(29,294)	(97,271)	(100,465)
Other income, net:
Interest income	5,453	3,616	14,423	10,651
Other (expense) income, net	(3)	33	(7)	67
Total other income, net	5,450	3,649	14,416	10,718
Net loss	(28,344)	(25,645)	(82,855)	(89,747)
Other comprehensive loss:
Net unrealized gain on investments	1,977	192	1,706	270
Comprehensive loss	$ (26,367)	$ (25,453)	$ (81,149)	$ (89,477)
Net loss per share, basic	$ (0.39)	$ (0.52)	$ (1.26)	$ (1.83)
Net loss per share, diluted	$ (0.39)	$ (0.52)	$ (1.26)	$ (1.83)
Weighted average shares used to compute net loss per share, basic	73,563,316	49,062,799	65,941,355	48,985,373
Weighted average shares used to compute net loss per share, diluted	73,563,316	49,062,799	65,941,355	48,985,373